Crime & Law · World
FDA Extends Safety Review of Abortion Pill, Drawing Criticism
The U.S. Food and Drug Administration (FDA) has announced that its safety review of the abortion pill mifepristone will continue into the next year. This decision has angered abortion rights opponents and is facing a court test. The FDA's ongoing review means the status of the pill's safety and accessibility remains under scrutiny.
How outlets across the spectrum covered it
L 0 C 3 R 0
- Centre (3): CBS News, Chicago Tribune, Politico